AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Telmikaa MT 25 Tablet ER

Prescription Icon
Prescription Required

Marketer

Troikaa Pharmaceuticals Ltd

Salt Composition

Telmisartan (40mg) + Metoprolol Succinate (25mg)

Overview Telmikaa MT 25 Tablet ER

Telmikaa MT 25 Extended-Release tablets manage hypertension, reducing the risk of strokes and heart attacks. Early use enhances survival rates following heart attacks. Consistent blood levels are achieved by taking this medication with food daily, at the same time, as prescribed. Continue treatment as directed; discontinuing prematurely, even feeling well, is risky, as hypertension often presents without symptoms. Lifestyle changes, including regular exercise, weight management, and a healthy diet, further support blood pressure control. Strictly adhere to your physician's instructions. Potential side effects include headache, fatigue, dizziness, low blood pressure, elevated potassium levels, occasional fainting (orthostatic hypotension), shortness of breath, nausea, vomiting, and abdominal discomfort. Avoid potassium-rich foods and supplements. Dizziness may occur; avoid driving and rise slowly from seated positions. Regular monitoring of blood pressure, blood sugar, kidney function, urea, and electrolyte levels may be necessary. Inform your doctor about any pre-existing liver or kidney conditions, or pregnancy/breastfeeding, before commencing treatment. Disclose all other medications, especially those for hypertension or heart ailments.

Primary Ingredients of Telmikaa MT 25 Tablet ER

No text provided to rephrase.

Uses of Telmikaa MT 25 Tablet ER

Managing Elevated Blood Pressure

Major Benefits of Telmikaa MT 25 Tablet ER:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Telmikaa MT 25 Tablet ER whole; do not crush, chew, or break it. Administer this medication with food.

Common Side effects of Telmikaa MT 25 Tablet ER:

  • Headache
  • Weakness
  • Dizziness
  • Cold extremities
  • Slow heart rate
  • Increased potassium level in blood
  • Decreased blood pressure
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Breathlessness
  • Vomiting
  • Abdominal pain

How to use Telmikaa MT 25 Tablet ER:

Consume this medication precisely as your physician directs, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Telmikaa MT 25 Extended-Release Tablet should be administered with a meal.

How Telmikaa MT 25 Tablet ER works:

Telmisartan and Metoprolol Succinate, combined in Telmikaa MT 25 Extended-Release Tablets, effectively reduce blood pressure.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Consuming alcohol while taking Telmikaa MT 25 Tablet ER is unsafe.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Telmikaa MT 25 tablets are contraindicated in pregnancy due to established fetal risk. In exceptional, life-threatening circumstances, a physician might prescribe them if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Telmisartan 25 mg tablets (Telmikaa MT 25) appear safe for breastfeeding mothers. Available human data indicate minimal risk to the infant.

DrivingDrivingUNSAFE

Extended-release Telmisartan 25 mg tablets can cause drowsiness, blurred vision, dizziness, and reduced alertness. Driving should be avoided if these effects are experienced.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Telmikaa MT 25 Tablet ER without requiring a dosage change.

LiverLiverCAUTION

Individuals with hepatic impairment should exercise caution when using Telmikaa MT 25 Extended-Release tablets. Dosage modification may be necessary. Physician consultation is advised.

What if you forget to take Telmikaa MT 25 Tablet ER :

Should you forget to take a Telmikaa MT 25 Tablet ER, ingest it immediately upon remembrance. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing pattern. Avoid taking a double dose.

Facts to Know About Telmikaa MT 25 Tablet ER

LabelValue
Developing Habits No.
Treatment Category Heart

FAQs on Telmikaa MT 25 Tablet ER

Dizziness is a possible side effect of Telmikaa MT 25 Tablet ER Succinate, particularly when standing up quickly from a lying or sitting position. To minimize this risk, stand slowly after sitting or lying down.
Improve your health by adopting a healthier lifestyle alongside Telmikaa MT 25 Tablet ER Succinate. Quitting smoking significantly reduces heart attack and stroke risk. Weight loss is beneficial if you're overweight or obese. Eat a balanced diet rich in fruits and vegetables. Regular physical activity strengthens the heart and lowers heart attack risk.
Continue taking Telmikaa MT 25 Tablet ER as prescribed, even if you feel healthy. Abruptly stopping this medication can cause serious complications, including heart attack and stroke.
Store this medication in its original, tightly closed container, as directed on the label or packaging. Discard any unused medication and keep it out of reach of children, pets, and others.
Telmikaa MT 25 Tablet ER
91
MRP 105
13% off